ArticleMolecular cancer2011

A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.

Shunsuke Meike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.